Clinical trial
Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung Cancer
NCT04003246
Study timeline
Study start (actual)2020-04-03Date precision: day
Registry last updated2025-03-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non Small Cell Lung Cancerunresolved
Lung Cancer Stage IIIunresolved
Interventions
Thoracic RT and DurvalumabRADIATION
Sponsors & collaborators
University of Texas Southwestern Medical Centerlead sponsor
AstraZenecacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04003246 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.